Prolonged survival after liver transplantation for Hodgkin's disease-induced fulminant liver failure

Hepato-Gastroenterology

Volumn 52, Issue 61, 2005, Pages 217-219

  Abdulkader, I ^a   Fraga, M ^a   Gonzalez Quintela A ^a   Caparrini, A ^a   Bello, J L ^a   Galban C ^a   Varo, E ^a   Diaz Mediavilla, J ^b   Forteza, J ^a  

^a University Hospital of Santiago de Compostela   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Hodgkin's disease; Liver transplantation

Indexed keywords

ADULT; ARTICLE; CANCER INFILTRATION; CANCER RECURRENCE; CANCER REGRESSION; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; LIVER FAILURE; LIVER TRANSPLANTATION; LYMPHOCYTE; MALE; PRIORITY JOURNAL;

ADULT; HODGKIN DISEASE; HUMANS; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; MALE; SURVIVORS; TREATMENT OUTCOME;

EID: 14144253192     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Saigal S, Norris S, Srinivassan P, Muiesan P, Rela M, Heaton N, O'Grady J: Succesful outcome of orthotopic liver transplantation in patients with preexisting malignant states. Liver Transpl 2001; 7:11-15.
2. Woolf GM, Petrovic LM, Rojter SE, Villamil FG, Makowka L, Podesta LG, Sher LS, Memsic L, Vierling JM: Acute liver failure due to lymphoma. A diagnostic concern when considering liver transplantation. Dig Dis Sci 1994; 39:1351-1358.
3. Rowbotham D, Wendon J, Williams R: Acute liver failure secondary to hepatic infiltration: a single centre experience of 18 cases. Gut 1998; 42:576-580.
4. Poppema S, Kaiserling E, Lennert K: Epidemiology of nodular paragranuloma (Hodgkin's disease with lymphocytic predominance, nodular). J Cancer Res Clin Oncol 1979; 95:57-63.
5. Regula DP, Hopper RT, Weiss LM: Nodular and diffuse types of lymphocyte predominance Hodgkin's disease. N Engl J Med 1988; 318:214-219.
6. Mason DY, Banks PM, Chan JC, Cleary ML, Delsol G, de Wolf Peeters C, Falini B, Gatter K, Grogan TM, Harris NL: Nodular lymphocyte predominance Hodgkin's disease. A distinct clinicopathological entity. Am J Surg Pathol 1994; 18:526-530.
7. Hansmann ML, Zwingers T, Boske A, Loffler H, Lennert K: Clinical features of nodular paragranuloma (Hodgkin's disease, lymphocyte predominance type, nodular). J Cancer Res Clin Oncol 1984; 108:321-330.
8. von Wasielewski R, Werner M, Fischer R, Hansmann ML, Hubner K, Hasenclever D, Franknin J, Sextro M, Diehl V, Georgii A: Lymphocyte-predominant Hodgkin's disease. An immunohistochemical analysis of 208 reviewed Hodgkin's disease cases from the German Hodgkin Study Group. Am J Pathol 1997; 150:793-803.
9. Siebert JB, Stuckey JH, Kurtin PJ, Banks PM: Extranodal lymphocyte predominance Hodgkin's disease: clinical and pathologic features. Am J Clin Pathol 1995; 103:485-491.
10. Chang KL, Kamel OW, Arber DA, Horyd ID, Weiss LM: Pathologic features of nodular lymphocyte predominance Hodgkin's disease in extranodal sites. Am J Surg Pathol 1995; 19:1313-1324.
11. Kamel O, Gelb A, Shibuha R, Warnke RA: Leu-7 (CD57) reactivity distinguishes nodular lymphocyte predominance Hodgkin's disease from nodular sclerosing Hodgkin's disease, T-cell-rich B-cell lymphoma and follicular lymphoma. Am J Pathol 1993; 142:541-546.
12. Fleming MD, Shahsafei A, Dorfman DM: Absence of dendritic reticulum cell staining is helpful for distinguishing T-cell-rich-B-cell lymphoma from lymphocyte predominance Hodgkin's disease. Appl Immunohistochem 1998; 6:16-22.
13. Dourakis SP, Tzemanakis E, Deutsch M, Kafiri G, Hadziyannis SJ: Fulminant hepatic failure as a presenting paraneoplastic manifestation of Hodgkin's disease. Eur J Gastroenterol Hepatol 1999; 11:1055-1058.
14. Penn I: The effect of immunosuppression on pre-existing cancers. Transplantation 1993; 55:742-747.
15. Stevens SJ, Verschuuren EA, Pronk I, van der Bij W, Harmsen MC, The TH, Meijer CJ, van den Brule AJ, Middledorp JM: Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients. Blood 2001; 97:1165-1171.